Alkermes PLC (ALKS)
23.74
-0.28
(-1.17%)
USD |
NASDAQ |
May 28, 16:00
23.74
0.00 (0.00%)
After-Hours: 20:00
Alkermes Total Return Level: 24.02 for May 24, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 24, 2024 | 24.02 |
May 23, 2024 | 24.00 |
May 22, 2024 | 24.21 |
May 21, 2024 | 24.34 |
May 20, 2024 | 24.38 |
May 17, 2024 | 24.15 |
May 16, 2024 | 24.46 |
May 15, 2024 | 24.14 |
May 14, 2024 | 24.49 |
May 13, 2024 | 24.71 |
May 10, 2024 | 24.05 |
May 09, 2024 | 24.26 |
May 08, 2024 | 24.10 |
May 07, 2024 | 24.59 |
May 06, 2024 | 24.10 |
May 03, 2024 | 24.05 |
May 02, 2024 | 23.86 |
May 01, 2024 | 24.01 |
April 30, 2024 | 24.54 |
April 29, 2024 | 24.88 |
April 26, 2024 | 24.68 |
April 25, 2024 | 24.44 |
April 24, 2024 | 24.65 |
April 23, 2024 | 24.26 |
April 22, 2024 | 24.07 |
Date | Value |
---|---|
April 19, 2024 | 23.85 |
April 18, 2024 | 23.76 |
April 17, 2024 | 24.01 |
April 16, 2024 | 23.77 |
April 15, 2024 | 24.02 |
April 12, 2024 | 24.42 |
April 11, 2024 | 24.99 |
April 10, 2024 | 26.14 |
April 09, 2024 | 26.73 |
April 08, 2024 | 25.93 |
April 05, 2024 | 26.12 |
April 04, 2024 | 25.81 |
April 03, 2024 | 26.33 |
April 02, 2024 | 26.77 |
April 01, 2024 | 27.24 |
March 28, 2024 | 27.07 |
March 27, 2024 | 27.25 |
March 26, 2024 | 26.78 |
March 25, 2024 | 27.31 |
March 22, 2024 | 27.29 |
March 21, 2024 | 26.97 |
March 20, 2024 | 27.71 |
March 19, 2024 | 27.70 |
March 18, 2024 | 27.53 |
March 15, 2024 | 28.75 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
13.06
Minimum
Mar 18 2020
33.63
Maximum
Jun 22 2023
23.88
Average
24.00
Median
Total Return Level Benchmarks
Endo International PLC (DELISTED) | 0.0006 |
Jazz Pharmaceuticals PLC | 106.06 |
Medtronic PLC | 141.96 |
Perrigo Co PLC | 35.18 |
Iterum Therapeutics PLC | 1.35 |